Wolvertem, Belgium

Sandra Van Lint

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Orionis Biosciences Bv, University of Ghent, Vib Vzw. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandra Van Lint. Retrieved from https://idiyas.com/inventor/sandra-van-lint

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Sandra Van Lint

Introduction: Sandra Van Lint is a notable inventor based in Wolvertem, Belgium, recognized for her contributions to the field of immunotherapy. With a significant patent to her name, she has made a remarkable impact on medical science through her innovative thinking and dedication.

Latest Patents: Sandra holds one patent titled "Bispecific signaling agents and uses thereof." This invention revolves around bispecific chimeric proteins designed for various immunotherapy applications. These proteins exhibit dual capabilities, including immune cell recruitment and immune signal delivery, showcasing her inventive prowess in enhancing therapeutic strategies.

Career Highlights: Throughout her career, Sandra has gained valuable experience working with esteemed organizations. She has been associated with Orionis Biosciences, where her focus on biotechnology has propelled advancements in therapeutic development. Additionally, her tenure at VIB continues to underline her dedication to research and innovation in life sciences.

Collaborations: Throughout her journey, Sandra has collaborated with prominent professionals in her field, including Nikolai Kley and Jan Tavernier. These partnerships have undoubtedly enriched her research endeavors and contributed to her accomplishments as an inventor.

Conclusion: Sandra Van Lint exemplifies the spirit of innovation within the scientific community. Her patent on bispecific signaling agents highlights her commitment to improving immunotherapy, making her an inspiring figure for aspiring inventors and researchers alike. Her work continues to pave the way for new therapeutic options, ultimately benefiting patients and the broader medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…